People · Operator
Named in public records as an officer, director or promoter · active 2019–2019 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Aerovate Therapeutics, Inc. | — | Pharmaceuticals | Series C | $78.3M | $2.6B | 2019 |
Benjamin Dake at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Benjamin Dake on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| ANDREW LEVIN | 1 | 17 |
| Joshua Resnick | 1 | 12 |
| James Schneider | 1 | 5 |
| Maha T. Katabi | 1 | 2 |
| David T. Grayzel | 1 | 1 |
| Benjamin T. Dake | 1 | 1 |
| Joshua T. Resnick | 1 | 1 |
| Jonathan T. Leff | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.